Latest News

Yiren Digital Files 2024 Annual Report on Form 20-F

BEIJING, April 28, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inChina, today announced that it has filed its annual report on Form 20-F for the fiscal year ended...

2025-04-28 20:21 2830

Marvion Inc. Announces Annual Financial Results for 2024 with 134% Gain in Year-to-Year Revenue

HONG KONG, April 28, 2025 /PRNewswire/ -- Marvion Inc. (OTC: MNVC) filed and reported the financial results with the period ended 31 December, 2025.  For annual fiscal period ended31 December, 2024, the company achieved a revenue of $1,544,108 with a gross profit of $763,805, which is 134% growth...

2025-04-28 20:03 2943

Sky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension

SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea and the developer of CART BP pro—a ring-type, cuffless device for 24-hour blood pressure monitoring—announced that a research presentation by ProfessorJin Oh Na introduced the application of CA...

2025-04-28 20:00 1870

Small Lab Co., Ltd., obtains FDA OTC approval. Leading the K-Beauty wave

SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- SmallLab Inc , a microneedle platform company, has received final approval from the U.S. Food and Drug Administration (FDA) for its over-the-counter (OTC) drug manufacturing facility.

2025-04-28 20:00 1685

Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)

* Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA® (infliximab-dyyb) * Findings reinforce clinical decision-making in long-term management of moderate-to-severe Crohn's disease and ulcerative colitis and underscore Celltrion's commitmen...

2025-04-28 20:00 3193

Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE

HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved Phase IIb clinical trial of KPG-818 capsule for the treatment of moderate to severe cutaneo...

2025-04-28 20:00 1858

TDH Holdings, Inc. Reports Full Year 2024 Audited Financial Results

BEIJING, April 28, 2025 /PRNewswire/ -- TDH Holdings, Inc. (NASDAQ: PETZ) ("TDH" or the "Company"), a PRC-based company that is an operator and manager of commercial real estate properties, announced today its financial results for the fiscal year endedDecember 31, 2024. Full Year 2024 Financial...

2025-04-28 20:00 3878

WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- On April 28, 2025, Woori Financial Group Inc. (NYSE:WF) (KRX:316140) filed its Annual Report on Form 20-F for the year endedDecember 31, 2024 with the U.S. Securities and Exchange Commission. The 2024 Annual Report on Form 20-F can be downloaded ...

2025-04-28 19:16 2145

Jianpu Technology Inc. Files 2024 Annual Report on Form 20-F

BEIJING, April 28, 2025 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu" or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China , today announced it filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2024 with the Securities and Exchange Com...

2025-04-28 19:08 2712

Health In Tech's CEO Tim Johnson Discusses Company in 2025, Revenue Growth, and Healthcare on "The Street Reports Podcast" Listen Now!

STUART, Fla., April 28, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to share that CEOTim Johnson was featured on The Street Reports Podcast. Listen now:  https://thestreetreports.com/health-in-technologys-nasdaq-...

2025-04-28 19:00 2459

Hello Group Files Annual Report on Form 20-F for Fiscal Year 2024

BEIJING, April 28, 2025 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today filed with the U.S. Securities and Exchange Commission its annual report on Form 20-F for the fiscal year ended December 31,...

2025-04-28 18:51 3443

WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY

* Total Revenue Reached RMB9.65 Billion, Up 21.0% Year-over-Year; among which Revenue from Continuing Operations ReachedRMB9.39 Billion, Up 23.1% Year-over-Year * Net Profit Attributable to the Owners of the Company Reached RMB3.67 Billion [1], Up 89.1% Year-over-Year; Diluted Earnings per Sha...

2025-04-28 17:33 3231

Bright Scholar Announces Unaudited Financial Results for the Second Quarter of Fiscal Year 2025

Net income from continuing operations increased 223.6% YoY to GBP3.2 million Management to hold a conference call today at 7:00 a.m. Eastern Time CAMBRIDGE, England and FOSHAN, China, April 28, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar," the "Company," "we" or...

2025-04-28 17:00 3482

Fair Home: Valued Effort: Pairwork App Launches in the US to Quantify Housework

TOKYO, April 28, 2025 /PRNewswire/ -- (HQ: Shinagawa-ku, Tokyo; President & CEO: Toshikazu Saito; hereinafter "mediba"), a group company of KDDI Corporation (Japanese major telecommunication company), will begin offering its "Pairwork" app to the U.S. market onApril 24, 2025, marking the start of ...

2025-04-28 14:00 2262

YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia

SHANGHAI, April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, announced promising interim clinical data from an investigator-initiated trial (IIT) of YOLT-101 (NCT064...

2025-04-28 13:22 2456

Sigenergy Becomes Australia's Top Battery Brand by Market Share, SunWiz Reports

SYDNEY, April 28, 2025 /PRNewswire/ -- Sigenergy, a leading energy innovator, was ranked the No. 1 battery manufacturer inAustralia by blended capacity[1] for the month ofMarch 2025, according to the latest report from SunWiz, an independent expert solar consultancy. Based on kilowatt-hours (kWh)...

2025-04-28 12:27 2712

2025 AACR | Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1

SHANGHAI, April 27, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics 02256.HK) today announced that it has presented four late-breaking pre-clinical research posters at the 2025 AACR conference held in Chicago, Illinois (USA) from April 25 to April 30. Results were shared ...

2025-04-28 10:00 4766

Lexar hosts international technology media tour in Zhongshan Industrial Park

SHENZHEN, China, April 27, 2025 /PRNewswire/ -- Lexar, a global consumer brand of data storage solutions conducted a 2-day media event participated by a select group of journalists from leading international technology publications, April 23-24, Zhongshan, China.

2025-04-28 10:00 2019

ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting

SUZHOU, China, April 27, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster presentation at American Association for Cancer Resea...

2025-04-28 09:00 2813

TIER IV accelerates the deployment of autonomous trucks following completion of Japanese government initiative

TOKYO, April 27, 2025 /PRNewswire/ -- TIER IV , the pioneering force behind the world's first open-source software for autonomous driving, is thrilled to announce the successful completion of an initiative aimed at developing autonomous trucks to address the critical shortag...

2025-04-28 09:00 2321